Modulation of in vitro autologous melanoma-specific cytotoxic T-cell responses by phorbol dibutyrate and ionomycin
- 1 February 1990
- journal article
- research article
- Published by Elsevier in Cellular Immunology
- Vol. 125 (2) , 508-517
- https://doi.org/10.1016/0008-8749(90)90103-x
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- New aspects of prolactin and immunity: a lymphocyte-derived prolactin-like product and nuclear protein kinase C activationTrends in Pharmacological Sciences, 1989
- Activation of human T cells with the physiological regulator of protein kinase CCellular Immunology, 1988
- Human Cytotoxic T Cells Specific for Autologous Melanoma Cells: Successful Generation From Lymph Node Cells in Seven Consecutive CasesJNCI Journal of the National Cancer Institute, 1988
- Autologous lymph node cell-derived tumor-specific cytotoxic t-cells for use in adoptive immunotherapy of human melanomaCancer, 1988
- Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study.Journal of Clinical Oncology, 1988
- The T Cell Receptor/CD3 Complex: A Dynamic Protein EnsembleAnnual Review of Immunology, 1988
- Human T Cells Specifically Activated Against Autologous Malignant MelanomaArchives of Surgery, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Endocytosis and recycling of the T3-T cell receptor complex. The role of T3 phosphorylation.The Journal of Experimental Medicine, 1987
- Direct induction of lymphocyte killing by calcium lonophore and phorbol ester treatmentCellular Immunology, 1987